14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $36.78 $42.85 Wednesday, 24th Apr 2024 CLDX stock ended at $37.02. This is 1.99% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.53% from a day low at $36.96 to a day high of $37.90.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jul 10, 2023 $35.60 $37.27 $35.60 $36.92 357 611
Jul 07, 2023 $35.72 $36.96 $35.18 $35.62 290 011
Jul 06, 2023 $34.98 $35.72 $34.24 $35.47 247 930
Jul 05, 2023 $34.74 $35.28 $34.05 $35.17 256 250
Jul 03, 2023 $33.69 $35.18 $33.53 $34.74 336 633
Jun 30, 2023 $34.94 $34.94 $33.67 $33.93 524 463
Jun 29, 2023 $35.15 $35.30 $34.38 $34.58 291 514
Jun 28, 2023 $34.83 $35.84 $34.35 $35.05 340 821
Jun 27, 2023 $35.53 $36.98 $34.75 $34.94 358 015
Jun 26, 2023 $35.29 $35.99 $35.00 $35.34 359 293
Jun 23, 2023 $36.34 $36.60 $35.26 $35.49 640 502
Jun 22, 2023 $36.89 $37.80 $36.04 $36.56 449 209
Jun 21, 2023 $36.40 $37.05 $36.20 $36.95 500 517
Jun 20, 2023 $35.70 $37.36 $35.50 $36.82 593 758
Jun 16, 2023 $37.47 $37.47 $35.48 $35.68 1 326 971
Jun 15, 2023 $37.36 $38.06 $36.64 $36.87 339 360
Jun 14, 2023 $38.25 $39.29 $37.17 $37.60 560 953
Jun 13, 2023 $37.19 $38.78 $37.06 $38.28 535 639
Jun 12, 2023 $35.65 $37.59 $35.20 $37.09 974 697
Jun 09, 2023 $35.74 $36.00 $34.53 $34.80 472 723
Jun 08, 2023 $35.05 $35.97 $34.55 $35.57 620 521
Jun 07, 2023 $35.07 $35.58 $34.32 $35.23 503 391
Jun 06, 2023 $34.02 $35.08 $33.78 $34.97 557 593
Jun 05, 2023 $32.85 $34.10 $32.80 $34.01 346 752
Jun 02, 2023 $32.68 $33.25 $31.93 $33.19 369 474
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT